Regina M. Paglia is CHRO at Dicerna Pharmaceuticals Inc (DRNA). They have made 11 open-market trades across 1 company since 2020, most recently 2021-07-06.
CIK 0001813985
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DRNA | 1,719 | $66K |
Shares reported on the most recent Form 4, priced at the 2021-07-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DRNA | SELL | 2021-06-25 | 2021-06-29 | $38.00 | $38K | +7.9% | +2.7% | -42.4% |
| DRNA | SELL | 2021-06-22 | 2021-06-24 | $37.00 | $1.4M | -1.0% | -3.4% | -47.5% |
| DRNA | SELL | 2021-06-17 | 2021-06-22 | $35.79 | $620K | +0.7% | +1.0% | -44.5% |
| DRNA | SELL | 2021-06-16 | 2021-06-17 | $35.63 | $2.2M | +1.3% | +8.1% | -40.3% |
| DRNA | SELL | 2021-06-01 | 2021-06-03 | $30.90 | $264K | +16.5% | +20.7% | -33.9% |
| DRNA | SELL | 2021-05-03 | 2021-05-05 | $30.23 | $254K | -6.9% | +11.1% | +31.8% |
| DRNA | SELL | 2021-04-01 | 2021-04-05 | $25.86 | $229K | +6.9% | +6.8% | +38.9% |
| DRNA | SELL | 2021-03-01 | 2021-03-02 | $28.96 | $128K | -5.8% | -12.7% | +4.1% |
| DRNA | SELL | 2021-02-02 | 2021-02-04 | $24.00 | $106K | +2.6% | +2.8% | +10.0% |
| DRNA | SELL | 2021-01-25 | 2021-01-27 | $25.00 | $158K | +15.9% | +11.2% | +24.8% |
| DRNA | SELL | 2020-11-04 | 2020-11-06 | $22.75 | $683K | -1.6% | +5.8% | +11.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.